| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.862 | 0.003 | 0.916 | Bronchodilator | 0.916 0.003 DBMET01394 | DBMET01394 | |
| 0.78 | 0.001 | 0.78 | Adrenaline agonist | 0.72 0.001 DBMET01394 | ||
| 0.767 | 0.001 | 0.767 | Beta 1 adrenoreceptor agonist | 0.583 0.001 DBMET01394 | ||
| 0.751 | 0.001 | 0.751 | Beta adrenoreceptor agonist | 0.683 0.001 DBMET01394 | ||
| 0.727 | 0.007 | 0.727 | Toll-Like receptor agonist | 0.685 0.01 DBMET01394 | ||
| 0.722 | 0.008 | 0.722 | Toll-Like receptor 7 agonist | 0.671 0.011 DBMET01394 | ||
| 0.7 | 0.006 | 0.843 | Spasmolytic | 0.843 0.004 DBMET01394 | DBMET01394 | |
| 0.638 | 0.001 | 0.638 | Beta 2 adrenoreceptor agonist | 0.554 0.001 DBMET01394 | ||
| 0.602 | 0.004 | 0.793 | Anesthetic local | 0.793 0.003 DBMET01394 | DBMET01394 | |
| 0.614 | 0.017 | 0.614 | Cholesterol antagonist | 0.573 0.022 DBMET01394 | ||
| 0.573 | 0.009 | 0.612 | Calcium channel L-type activator | 0.612 0.005 DBMET01394 | DBMET01394 | |
| 0.543 | 0.029 | 0.57 | Antiobesity | 0.57 0.025 DBMET01394 | DBMET01394 | |
| 0.522 | 0.044 | 0.587 | Cyclophilin D inhibitor | 0.587 0.03 DBMET01394 | DBMET01394 | |
| 0.445 | 0.012 | 0.445 | Calcium channel activator | 0.427 0.016 DBMET01394 | ||
| 0.431 | 0.027 | 0.529 | Vasodilator, coronary | 0.529 0.012 DBMET01394 | DBMET01394 | |
| 0.389 | 0.002 | 0.486 | Beta adrenoreceptor antagonist | 0.486 0.002 DBMET01394 | DBMET01394 | |
| 0.44 | 0.055 | 0.538 | Transcription factor NF kappa B inhibitor | 0.538 0.039 DBMET01394 | DBMET01394 | |
| 0.429 | 0.046 | 0.687 | Vasodilator, peripheral | 0.687 0.007 DBMET01394 | DBMET01394 | |
| 0.406 | 0.026 | 0.456 | Interleukin 2 agonist | 0.456 0.014 DBMET01394 | DBMET01394 | |
| 0.414 | 0.054 | 0.414 | Calpain 2 inhibitor | 0.27 0.135 DBMET01394 | ||
| 0.344 | 0.006 | 0.402 | Acetylcholine muscarinic antagonist | 0.402 0.005 DBMET01394 | DBMET01394 | |
| 0.34 | 0.002 | 0.467 | Beta 2 adrenoreceptor antagonist | 0.467 0.002 DBMET01394 | DBMET01394 | |
| 0.39 | 0.053 | 0.448 | Immunostimulant | 0.448 0.037 DBMET01394 | DBMET01394 | |
| 0.386 | 0.053 | 0.478 | Antithrombotic | 0.478 0.032 DBMET01394 | DBMET01394 | |
| 0.331 | 0.004 | 0.335 | Acetylcholine M3 receptor antagonist | 0.335 0.004 DBMET01394 | DBMET01394 | |
| 0.337 | 0.011 | 0.445 | Antiadrenergic | 0.445 0.007 DBMET01394 | DBMET01394 | |
| 0.335 | 0.011 | 0.443 | Adrenaline antagonist | 0.443 0.007 DBMET01394 | DBMET01394 | |
| 0.325 | 0.002 | 0.325 | Beta 3 adrenoreceptor agonist | 0.317 0.002 DBMET01394 | ||
| 0.323 | 0.011 | 0.403 | Acetylcholine M1 receptor antagonist | 0.403 0.005 DBMET01394 | DBMET01394 | |
| 0.326 | 0.037 | 0.479 | Interleukin agonist | 0.479 0.01 DBMET01394 | DBMET01394 | |
| 0.307 | 0.022 | 0.353 | Peptidyltransferase inhibitor | 0.353 0.012 DBMET01394 | DBMET01394 | |
| 0.29 | 0.015 | 0.402 | Cholinergic antagonist | 0.402 0.008 DBMET01394 | DBMET01394 | |
| 0.286 | 0.015 | 0.398 | Acetylcholine antagonist | 0.398 0.008 DBMET01394 | DBMET01394 | |
| 0.258 | 0.003 | 0.324 | Beta 1 adrenoreceptor antagonist | 0.324 0.002 DBMET01394 | DBMET01394 | |
| 0.287 | 0.057 | 0.347 | Hypoglycemic | 0.347 0.038 DBMET01394 | DBMET01394 | |
| 0.238 | 0.026 | 0.279 | Phospholipase A2 inhibitor | 0.279 0.017 DBMET01394 | DBMET01394 | |
| 0.266 | 0.061 | 0.378 | Vasodilator | 0.378 0.027 DBMET01394 | DBMET01394 | |
| 0.241 | 0.04 | 0.271 | Insulin sensitizer | 0.271 0.024 DBMET01394 | DBMET01394 | |
| 0.308 | 0.11 | 0.365 | Immunosuppressant | 0.365 0.079 DBMET01394 | DBMET01394 | |
| 0.213 | 0.019 | 0.213 | Antibacterial (Helicobacter pylori) | 0.167 0.035 DBMET01394 | ||
| 0.215 | 0.023 | 0.387 | Adenylate cyclase inhibitor | 0.387 0.008 DBMET01394 | DBMET01394 | |
| 0.257 | 0.067 | 0.334 | Angiogenesis stimulant | 0.334 0.037 DBMET01394 | DBMET01394 | |
| 0.203 | 0.012 | 0.282 | Adenylate cyclase stimulant | 0.282 0.003 DBMET01394 | DBMET01394 | |
| 0.191 | 0.006 | 0.281 | Interferon agonist | 0.281 0.004 DBMET01394 | DBMET01394 | |
| 0.188 | 0.004 | 0.237 | Beta 3 adrenoreceptor antagonist | 0.237 0.004 DBMET01394 | DBMET01394 | |
| 0.232 | 0.051 | 0.232 | Non-steroidal antiinflammatory agent | 0.175 0.091 DBMET01394 | ||
| 0.248 | 0.068 | 0.336 | Hypolipemic | 0.336 0.039 DBMET01394 | DBMET01394 | |
| 0.24 | 0.062 | 0.358 | Psychostimulant | 0.358 0.03 DBMET01394 | DBMET01394 | |
| 0.182 | 0.018 | 0.265 | Mucolytic | 0.265 0.005 DBMET01394 | DBMET01394 | |
| 0.167 | 0.015 | 0.221 | Aminoacyl-tRNA synthetase inhibitor | 0.221 0.009 DBMET01394 | DBMET01394 | |
| 0.157 | 0.007 | 0.235 | Acetylcholine M5 receptor antagonist | 0.235 0.004 DBMET01394 | DBMET01394 | |
| 0.239 | 0.09 | 0.307 | Antioxidant | 0.307 0.059 DBMET01394 | DBMET01394 | |
| 0.145 | 0.004 | 0.152 | Glucosylceramidase inhibitor | 0.152 0.004 DBMET01394 | DBMET01394 | |
| 0.173 | 0.032 | 0.203 | Cyclooxygenase 3 inhibitor | 0.203 0.017 DBMET01394 | DBMET01394 | |
| 0.139 | 0.005 | 0.201 | Interferon inducer | 0.201 0.003 DBMET01394 | DBMET01394 | |
| 0.163 | 0.031 | 0.275 | Expectorant | 0.275 0.01 DBMET01394 | DBMET01394 | |
| 0.228 | 0.097 | 0.294 | Cardiotonic | 0.294 0.059 DBMET01394 | DBMET01394 | |
| 0.165 | 0.042 | 0.236 | Toll-Like receptor 2 antagonist | 0.236 0.012 DBMET01394 | DBMET01394 | |
| 0.184 | 0.063 | 0.209 | Succinate dehydrogenase inhibitor | 0.209 0.042 DBMET01394 | DBMET01394 | |
| 0.203 | 0.083 | 0.203 | Nitric-oxide synthase stimulant | 0.202 0.086 DBMET01394 | ||
| 0.171 | 0.055 | 0.343 | Amylase inhibitor | 0.343 0.014 DBMET01394 | DBMET01394 | |
| 0.133 | 0.021 | 0.175 | Toll-Like receptor 3 antagonist | 0.175 0.009 DBMET01394 | DBMET01394 | |
| 0.176 | 0.07 | 0.176 | Growth hormone agonist | 0.139 0.097 DBMET01394 | ||
| 0.174 | 0.068 | 0.347 | Phospholipase C inhibitor | 0.347 0.014 DBMET01394 | DBMET01394 | |
| 0.208 | 0.106 | 0.208 | Calpain inhibitor | |||
| 0.122 | 0.023 | 0.122 | Interleukin 5 antagonist | 0.112 0.03 DBMET01394 | ||
| 0.237 | 0.14 | 0.272 | Apoptosis antagonist | 0.272 0.107 DBMET01394 | DBMET01394 | |
| 0.13 | 0.034 | 0.143 | Sphingomyelinase inhibitor | 0.143 0.027 DBMET01394 | DBMET01394 | |
| 0.121 | 0.029 | 0.121 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.132 | 0.044 | 0.223 | Chelator | 0.223 0.02 DBMET01394 | DBMET01394 | |
| 0.089 | 0.003 | 0.089 | Ceramide glucosyltransferase inhibitor | 0.077 0.003 DBMET01394 | ||
| 0.139 | 0.053 | 0.347 | Alkylator | 0.347 0.01 DBMET01394 | DBMET01394 | |
| 0.175 | 0.091 | 0.31 | Amyloid beta aggregation inhibitor | 0.31 0.043 DBMET01394 | DBMET01394 | |
| 0.12 | 0.039 | 0.152 | Anabolic | 0.152 0.017 DBMET01394 | DBMET01394 | |
| 0.087 | 0.009 | 0.153 | Alpha-mannosidase inhibitor | 0.153 0.004 DBMET01394 | DBMET01394 | |
| 0.119 | 0.044 | 0.194 | Gastric antisecretory | 0.194 0.013 DBMET01394 | DBMET01394 | |
| 0.185 | 0.11 | 0.234 | Free radical scavenger | 0.234 0.076 DBMET01394 | DBMET01394 | |
| 0.199 | 0.124 | 0.336 | DNA synthesis inhibitor | 0.336 0.033 DBMET01394 | DBMET01394 | |
| 0.143 | 0.071 | 0.143 | MAP3K9 inhibitor | 0.135 0.085 DBMET01394 | ||
| 0.237 | 0.166 | 0.447 | Histamine release inhibitor | 0.447 0.052 DBMET01394 | DBMET01394 | |
| 0.093 | 0.025 | 0.093 | Leukotriene antagonist | 0.084 0.029 DBMET01394 | ||
| 0.09 | 0.024 | 0.177 | Acetylcholine M2 receptor antagonist | 0.177 0.008 DBMET01394 | DBMET01394 | |
| 0.149 | 0.083 | 0.251 | Melanin inhibitor | 0.251 0.028 DBMET01394 | DBMET01394 | |
| 0.075 | 0.01 | 0.141 | Mannosidase inhibitor | 0.141 0.004 DBMET01394 | DBMET01394 | |
| 0.137 | 0.072 | 0.195 | Neurotrophic factor | 0.195 0.03 DBMET01394 | DBMET01394 | |
| 0.087 | 0.023 | 0.087 | Prostaglandin EP2 antagonist | |||
| 0.075 | 0.011 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.008 DBMET01394 | DBMET01394 | |
| 0.168 | 0.105 | 0.204 | Interleukin antagonist | 0.204 0.082 DBMET01394 | DBMET01394 | |
| 0.131 | 0.07 | 0.177 | Interleukin 4 antagonist | 0.177 0.031 DBMET01394 | DBMET01394 | |
| 0.076 | 0.015 | 0.076 | Sphingosine 1-phosphate receptor 1 antagonist | 0.059 0.031 DBMET01394 | ||
| 0.121 | 0.061 | 0.261 | Monophenol monooxygenase inhibitor | 0.261 0.023 DBMET01394 | DBMET01394 | |
| 0.128 | 0.069 | 0.181 | Vanilloid 1 agonist | 0.181 0.018 DBMET01394 | DBMET01394 | |
| 0.081 | 0.024 | 0.096 | Maillard reaction inhibitor | 0.096 0.018 DBMET01394 | DBMET01394 | |
| 0.26 | 0.204 | 0.334 | Apoptosis agonist | 0.334 0.149 DBMET01394 | DBMET01394 | |
| 0.133 | 0.077 | 0.134 | Farnesoid X receptor antagonist | 0.134 0.075 DBMET01394 | DBMET01394 | |
| 0.111 | 0.057 | 0.148 | Mediator release inhibitor | 0.148 0.029 DBMET01394 | DBMET01394 | |
| 0.058 | 0.005 | 0.058 | Sodium/glucose cotransporter 2 inhibitor | 0.046 0.007 DBMET01394 | ||
| 0.094 | 0.043 | 0.119 | Glutathione S-transferase inhibitor | 0.119 0.023 DBMET01394 | DBMET01394 | |
| 0.054 | 0.005 | 0.054 | Sodium/glucose cotransporter inhibitor | 0.037 0.008 DBMET01394 | ||
| 0.114 | 0.07 | 0.114 | Cell adhesion inhibitor | |||
| 0.05 | 0.007 | 0.05 | Bradykinin B2 receptor antagonist | |||
| 0.063 | 0.022 | 0.063 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.197 | 0.159 | 0.197 | 5 Hydroxytryptamine uptake stimulant | 0.186 0.183 DBMET01394 | ||
| 0.141 | 0.104 | 0.183 | Nitric oxide antagonist | 0.183 0.075 DBMET01394 | DBMET01394 | |
| 0.091 | 0.055 | 0.154 | Ornithine decarboxylase inhibitor | 0.154 0.01 DBMET01394 | DBMET01394 | |
| 0.054 | 0.02 | 0.07 | Cytokine production stimulant | 0.07 0.007 DBMET01394 | DBMET01394 | |
| 0.088 | 0.055 | 0.095 | Transcription factor NF kappa B stimulant | 0.095 0.044 DBMET01394 | DBMET01394 | |
| 0.042 | 0.011 | 0.042 | Prostaglandin D2 agonist | 0.04 0.013 DBMET01394 | ||
| 0.104 | 0.073 | 0.113 | Electron transport complex I inhibitor | 0.113 0.057 DBMET01394 | DBMET01394 | |
| 0.057 | 0.026 | 0.057 | Phosphorylase inhibitor | |||
| 0.077 | 0.046 | 0.077 | Lipase inhibitor | 0.071 0.053 DBMET01394 | ||
| 0.162 | 0.132 | 0.219 | Platelet antagonist | 0.219 0.088 DBMET01394 | DBMET01394 | |
| 0.067 | 0.038 | 0.079 | Nitric oxide donor | 0.079 0.023 DBMET01394 | DBMET01394 | |
| 0.098 | 0.07 | 0.156 | Carbonic anhydrase XV inhibitor | 0.156 0.029 DBMET01394 | DBMET01394 | |
| 0.171 | 0.144 | 0.36 | DNA damaging | 0.36 0.038 DBMET01394 | DBMET01394 | |
| 0.078 | 0.051 | 0.078 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.098 | 0.073 | 0.098 | Toll-Like receptor 4 antagonist | 0.098 0.074 DBMET01394 | ||
| 0.056 | 0.031 | 0.056 | Thromboxane A2 antagonist | 0.056 0.031 DBMET01394 | ||
| 0.057 | 0.035 | 0.057 | Thromboxane antagonist | 0.054 0.038 DBMET01394 | ||
| 0.048 | 0.026 | 0.049 | Sphingosine 1-phosphate receptor agonist | 0.049 0.025 DBMET01394 | DBMET01394 | |
| 0.158 | 0.137 | 0.349 | Antiamyloidogenic | 0.349 0.039 DBMET01394 | DBMET01394 | |
| 0.117 | 0.096 | 0.258 | Protein kinase stimulant | 0.258 0.024 DBMET01394 | DBMET01394 | |
| 0.108 | 0.088 | 0.122 | Nav1.3 sodium channel blocker | 0.122 0.072 DBMET01394 | DBMET01394 | |
| 0.082 | 0.065 | 0.097 | Vanilloid agonist | 0.097 0.036 DBMET01394 | DBMET01394 | |
| 0.05 | 0.034 | 0.059 | Squalene epoxidase inhibitor | 0.059 0.022 DBMET01394 | DBMET01394 | |
| 0.138 | 0.123 | 0.151 | Hepatoprotectant | 0.151 0.108 DBMET01394 | DBMET01394 | |
| 0.063 | 0.047 | 0.075 | Selectin antagonist | 0.075 0.039 DBMET01394 | DBMET01394 | |
| 0.037 | 0.022 | 0.06 | Phosphoglycerate kinase inhibitor | 0.06 0.011 DBMET01394 | DBMET01394 | |
| 0.115 | 0.1 | 0.174 | Lipid peroxidase inhibitor | 0.174 0.053 DBMET01394 | DBMET01394 | |
| 0.033 | 0.019 | 0.039 | Prostaglandin agonist | 0.039 0.014 DBMET01394 | DBMET01394 | |
| 0.117 | 0.104 | 0.117 | Cell wall synthesis inhibitor | |||
| 0.042 | 0.029 | 0.049 | Sphingosine 1-phosphate receptor 1 agonist | 0.049 0.021 DBMET01394 | DBMET01394 | |
| 0.038 | 0.024 | 0.038 | Bradykinin antagonist | |||
| 0.029 | 0.016 | 0.029 | Prostaglandin EP4 antagonist | |||
| 0.029 | 0.017 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 DBMET01394 | DBMET01394 | |
| 0.1 | 0.088 | 0.117 | Cholesterol synthesis inhibitor | 0.117 0.068 DBMET01394 | DBMET01394 | |
| 0.071 | 0.06 | 0.099 | Topoisomerase II alpha inhibitor | 0.099 0.04 DBMET01394 | DBMET01394 | |
| 0.051 | 0.041 | 0.059 | Leukotriene B4 antagonist | 0.059 0.029 DBMET01394 | DBMET01394 | |
| 0.038 | 0.029 | 0.041 | Dopamine D3 agonist | 0.041 0.026 DBMET01394 | DBMET01394 | |
| 0.14 | 0.133 | 0.175 | P-glycoprotein inhibitor | 0.175 0.084 DBMET01394 | DBMET01394 | |
| 0.054 | 0.048 | 0.079 | Sphingosine 1-phosphate receptor 3 antagonist | 0.079 0.018 DBMET01394 | DBMET01394 | |
| 0.05 | 0.047 | 0.065 | Sphingosine kinase 2 inhibitor | 0.065 0.026 DBMET01394 | DBMET01394 | |
| 0.214 | 0.213 | 0.252 | Antibacterial | 0.252 0.175 DBMET01394 | DBMET01394 | |
| 0.02 | 0.019 | 0.02 | Alpha 1a adrenoreceptor agonist | 0.02 0.019 DBMET01394 | ||
| 0.118 | 0.118 | 0.152 | Hemostatic | 0.152 0.065 DBMET01394 | DBMET01394 | |
| 0.023 | 0.026 | 0.027 | Acid ceramidase inhibitor | 0.027 0.013 DBMET01394 | DBMET01394 | |
| 0.012 | 0.015 | 0.015 | Calcium-sensing receptor antagonist | 0.015 0.011 DBMET01394 | DBMET01394 | |
| 0.08 | 0.083 | 0.089 | Butyrylcholinesterase inhibitor | 0.089 0.072 DBMET01394 | DBMET01394 | |
| 0.095 | 0.099 | 0.201 | Photosensitizer | 0.201 0.013 DBMET01394 | DBMET01394 | |
| 0.043 | 0.048 | 0.064 | Lysophosphatidic acid 3 receptor antagonist | 0.064 0.019 DBMET01394 | DBMET01394 | |
| 0.036 | 0.043 | 0.051 | Oleamide hydrolase inhibitor | 0.051 0.026 DBMET01394 | DBMET01394 | |
| 0.13 | 0.137 | 0.326 | Anesthetic general | 0.326 0.028 DBMET01394 | DBMET01394 | |
| 0.017 | 0.025 | 0.022 | Prostaglandin E2 agonist | 0.022 0.018 DBMET01394 | DBMET01394 | |
| 0.015 | 0.024 | 0.039 | Prostaglandin EP2 agonist | 0.039 0.009 DBMET01394 | DBMET01394 | |
| 0.064 | 0.075 | 0.085 | Somatostatin 1 agonist | 0.085 0.046 DBMET01394 | DBMET01394 | |
| 0.023 | 0.034 | 0.044 | Sphingosine 1-phosphate receptor 3 agonist | 0.044 0.019 DBMET01394 | DBMET01394 | |
| 0.051 | 0.062 | 0.055 | Leukotriene C antagonist | 0.055 0.045 DBMET01394 | DBMET01394 | |
| 0.019 | 0.031 | 0.025 | Leukotriene B4 receptor 1 antagonist | 0.025 0.022 DBMET01394 | DBMET01394 | |
| 0.055 | 0.069 | 0.081 | Neuraminidase (influenza) inhibitor | 0.081 0.024 DBMET01394 | DBMET01394 | |
| 0.049 | 0.066 | 0.064 | Sphingosine kinase inhibitor | 0.064 0.032 DBMET01394 | DBMET01394 | |
| 0.084 | 0.105 | 0.101 | Nav1.4 sodium channel blocker | 0.101 0.075 DBMET01394 | DBMET01394 | |
| 0.045 | 0.066 | 0.064 | Epithelial sodium channel blocker | 0.064 0.023 DBMET01394 | DBMET01394 | |
| 0.062 | 0.084 | 0.083 | Calcium antagonist | 0.083 0.061 DBMET01394 | DBMET01394 | |
| 0.027 | 0.051 | 0.048 | Dopamine D2 agonist | 0.048 0.028 DBMET01394 | DBMET01394 | |
| 0.076 | 0.101 | 0.104 | Carbonic anhydrase III inhibitor | 0.104 0.058 DBMET01394 | DBMET01394 | |
| 0.092 | 0.118 | 0.102 | Estrogen antagonist | 0.102 0.095 DBMET01394 | DBMET01394 | |
| 0.02 | 0.05 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.022 DBMET01394 | DBMET01394 | |
| 0.048 | 0.08 | 0.167 | Phenylalanine 4-hydroxylase inhibitor | 0.167 0.009 DBMET01394 | DBMET01394 | |
| 0.014 | 0.05 | 0.022 | Prostaglandin F2 alpha agonist | 0.022 0.016 DBMET01394 | DBMET01394 | |
| 0.012 | 0.051 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.007 DBMET01394 | DBMET01394 | |
| 0.022 | 0.067 | 0.065 | Toll-Like receptor 2 agonist | 0.065 0.019 DBMET01394 | DBMET01394 | |
| 0.028 | 0.073 | 0.038 | Sphingosine kinase 1 inhibitor | 0.038 0.035 DBMET01394 | DBMET01394 | |
| 0.01 | 0.057 | 0.016 | Vitamin D receptor agonist | 0.016 0.012 DBMET01394 | DBMET01394 | |
| 0.034 | 0.088 | 0.07 | Neuraminidase inhibitor | 0.07 0.033 DBMET01394 | DBMET01394 | |
| 0.101 | 0.155 | 0.151 | Sphingosine 1-phosphate receptor 2 antagonist | 0.151 0.04 DBMET01394 | DBMET01394 | |
| 0.014 | 0.074 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.028 0.013 DBMET01394 | DBMET01394 | |
| 0.038 | 0.103 | 0.055 | Acetyl-CoA transferase 2 inhibitor | 0.055 0.044 DBMET01394 | DBMET01394 | |
| 0.102 | 0.17 | 0.147 | Platelet adhesion inhibitor | 0.147 0.109 DBMET01394 | DBMET01394 | |
| 0.052 | 0.122 | 0.078 | Carbonic anhydrase VI inhibitor | 0.078 0.06 DBMET01394 | DBMET01394 | |
| 0.025 | 0.101 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.034 DBMET01394 | DBMET01394 | |
| 0.021 | 0.097 | 0.044 | Antimetabolite | 0.044 0.036 DBMET01394 | DBMET01394 | |
| 0.038 | 0.115 | 0.068 | Histidine decarboxylase inhibitor | 0.068 0.053 DBMET01394 | DBMET01394 | |
| 0.004 | 0.083 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET01394 | DBMET01394 | |
| 0.217 | 0.296 | 0.304 | Caspase 9 stimulant | 0.304 0.19 DBMET01394 | DBMET01394 | |
| 0.126 | 0.205 | 0.154 | Growth factor agonist | 0.154 0.132 DBMET01394 | DBMET01394 | |
| 0.074 | 0.161 | 0.146 | Aldehyde dehydrogenase inhibitor | 0.146 0.05 DBMET01394 | DBMET01394 | |
| 0.019 | 0.115 | 0.057 | Adenosine deaminase inhibitor | 0.057 0.023 DBMET01394 | DBMET01394 | |
| 0.058 | 0.16 | 0.092 | mTOR complex 2 inhibitor | 0.092 0.044 DBMET01394 | DBMET01394 | |
| 0.047 | 0.151 | 0.087 | Topoisomerase I inhibitor | 0.087 0.082 DBMET01394 | DBMET01394 | |
| 0.07 | 0.175 | 0.128 | Thrombolytic | 0.128 0.101 DBMET01394 | DBMET01394 | |
| 0.035 | 0.143 | 0.092 | Glutamate decarboxylase inhibitor | 0.092 0.034 DBMET01394 | DBMET01394 | |
| 0.064 | 0.175 | 0.089 | Interleukin 12 antagonist | 0.089 0.075 DBMET01394 | DBMET01394 | |
| 0.043 | 0.166 | 0.104 | Aminopeptidase B inhibitor | 0.104 0.062 DBMET01394 | DBMET01394 | |
| 0.007 | 0.13 | 0.026 | Uridine phosphorylase inhibitor | 0.026 0.021 DBMET01394 | DBMET01394 | |
| 0.024 | 0.153 | 0.089 | Phosphofructokinase-1 inhibitor | 0.089 0.036 DBMET01394 | DBMET01394 | |
| 0.047 | 0.206 | 0.08 | Triose-phosphate isomerase inhibitor | 0.08 0.076 DBMET01394 | DBMET01394 | |
| 0.026 | 0.192 | 0.074 | Na+ K+ transporting ATPase inhibitor | 0.074 0.057 DBMET01394 | DBMET01394 | |
| 0.04 | 0.207 | 0.11 | Keratolytic | 0.11 0.025 DBMET01394 | DBMET01394 | |
| 0.055 | 0.261 | 0.092 | Adenylate kinase inhibitor | 0.092 0.082 DBMET01394 | DBMET01394 | |
| 0.057 | 0.268 | 0.117 | Peroxidase inhibitor | 0.117 0.103 DBMET01394 | DBMET01394 | |
| 0.119 | 0.335 | 0.226 | Sodium/bile acid cotransporter inhibitor | 0.226 0.155 DBMET01394 | DBMET01394 | |
| 0.051 | 0.276 | 0.093 | Phosphodiesterase 6D inhibitor | 0.093 0.067 DBMET01394 | DBMET01394 | |
| 0.051 | 0.296 | 0.109 | Acetylcholine release stimulant | 0.109 0.068 DBMET01394 | DBMET01394 | |
| 0.087 | 0.338 | 0.186 | Superoxide dismutase inhibitor | 0.186 0.134 DBMET01394 | DBMET01394 | |
| 0.036 | 0.333 | 0.113 | Alpha-N-acetylglucosaminidase inhibitor | 0.113 0.085 DBMET01394 | DBMET01394 | |
| 0.07 | 0.367 | 0.172 | Cyclic AMP phosphodiesterase inhibitor | 0.172 0.12 DBMET01394 | DBMET01394 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |